LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapeutics Globavir Biosciences focuses on rapid development of therapeutics for infectious diseases like dengue and other viral illnesses, presenting opportunities for collaborations or supply of advanced diagnostic tools and antiviral compounds.

Strategic Partnerships The company's recent partnership with Bio-Rad Laboratories highlights their openness to strategic alliances, which can be leveraged to offer complementary diagnostics, testing platforms, or co-development services to expand their reach.

Regulatory Advantage Using the 505(b)2 regulatory pathway, Globavir can rapidly bring new therapies to market, indicating a potential need for expedited manufacturing, regulatory consulting, and quality assurance services.

Broad Viral Focus With candidate compounds targeting multiple high-impact viruses beyond dengue, Globavir presents opportunities for supply chain solutions, specialty reagents, or targeted diagnostic kits across various viral markets.

Funding & Growth With $4M in funding, the firm is positioned for expansion and further R&D, creating prospects for investment, licensing agreements, or technology licensing to accelerate product pipelines.

Globavir Biosciences, Inc. Tech Stack

Globavir Biosciences, Inc. uses 8 technology products and services including WordPress Super Cache, MySQL, Google Fonts API, and more. Explore Globavir Biosciences, Inc.'s tech stack below.

  • WordPress Super Cache
    Caching
  • MySQL
    Database
  • Google Fonts API
    Font Scripts
  • Modernizr
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics
  • Apache
    Web Servers

Globavir Biosciences, Inc.'s Email Address Formats

Globavir Biosciences, Inc. uses at least 1 format(s):
Globavir Biosciences, Inc. Email FormatsExamplePercentage
First.Last@globavir.comJohn.Doe@globavir.com
43%
FirstLast@globavir.comJohnDoe@globavir.com
7%
First.Last@globavir.comJohn.Doe@globavir.com
43%
FirstLast@globavir.comJohnDoe@globavir.com
7%

Frequently Asked Questions

Where is Globavir Biosciences, Inc.'s headquarters located?

Minus sign iconPlus sign iconGlobavir Biosciences, Inc.'s main headquarters is located at 5150 EL CAMINO REAL Los Altos, California 94022 US. The company has employees across 1 continents, including North America.

What is Globavir Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign iconGlobavir Biosciences, Inc.'s official website is globavir.com and has social profiles on LinkedIn.

What is Globavir Biosciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconGlobavir Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Globavir Biosciences, Inc. have currently?

Minus sign iconPlus sign iconAs of March 2022, Globavir Biosciences, Inc. has approximately 11 employees across 1 continents, including North America. Key team members include Vice President Of Corporate Development: L. N.Director: J. R.Senior Scientist: J. C.. Explore Globavir Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Globavir Biosciences, Inc. belong to?

Minus sign iconPlus sign iconGlobavir Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Globavir Biosciences, Inc. use?

Minus sign iconPlus sign iconGlobavir Biosciences, Inc.'s tech stack includes WordPress Super CacheMySQLGoogle Fonts APIModernizrjQuery MigrateBootstrapGoogle AnalyticsApache.

What is Globavir Biosciences, Inc.'s email format?

Minus sign iconPlus sign iconGlobavir Biosciences, Inc.'s email format typically follows the pattern of First.Last@globavir.com. Find more Globavir Biosciences, Inc. email formats with LeadIQ.

How much funding has Globavir Biosciences, Inc. raised to date?

Minus sign iconPlus sign icon As of March 2022, Globavir Biosciences, Inc. has raised $4M in funding. The last funding round occurred on May 01, 2018 for $4M.

When was Globavir Biosciences, Inc. founded?

Minus sign iconPlus sign iconGlobavir Biosciences, Inc. was founded in 2011.

Globavir Biosciences, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the treatment of global infectious diseases.  Globavir's development strategy harnesses the  advantages offered by the 505(b)2 regulatory pathway, allowing for rapid development of new therapies.  

Globavir is initially focused on the treatment of dengue virus infection, a potentially lethal disease infecting 390 million patients annually.  Through the combination of our proprietary diagnostic technology and advanced therapeutic candidates, Globavir is ideally positioned to rapidly impact the clinical landscape for Dengue patients.  

Globavir's platform discovery technologies have further identified candidate compounds with efficacy in additional viral indications, including West Nile, Japanese Encephalitis, Ebola, Marburg, and Hunta viruses.

Section iconCompany Overview

Headquarters
5150 EL CAMINO REAL Los Altos, California 94022 US
Website
globavir.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $4M

    Globavir Biosciences, Inc. has raised a total of $4M of funding over 4 rounds. Their latest funding round was raised on May 01, 2018 in the amount of $4M.

  • $1M

    Globavir Biosciences, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $4M

    Globavir Biosciences, Inc. has raised a total of $4M of funding over 4 rounds. Their latest funding round was raised on May 01, 2018 in the amount of $4M.

  • $1M

    Globavir Biosciences, Inc.'s revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    L. N.
    Vice President Of Corporate Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. R.
    Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    Senior Scientist
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.